Formulations of the Future: Assessing the Shift Between Oral and Topical Rosacea Treatment Market Segment Preferences
The battle for dominance between oral and topical administrations has taken a decisive turn in 2026. For decades, oral antibiotics were the "hammer" used to treat the inflammatory "nail" of rosacea. However, growing concerns regarding antibiotic resistance and the disruption of the gut microbiome have led both patients and doctors to favor localized therapies. Modern topical agents, such as...
0 Commentarios 0 Shares